MedPath

Butalbital, Aspirin and Caffeine

Butalbital, Aspirin and Caffeine Tablets, USP

Approved
Approval ID

657e4c4a-e50c-49f7-99b4-32395ec19bd8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 29, 2011

Manufacturers
FDA

Dispensing Solutions, Inc.

DUNS: 066070785

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Butalbital, Aspirin and Caffeine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66336-619
Application NumberANDA086162
Product Classification
M
Marketing Category
C73584
G
Generic Name
Butalbital, Aspirin and Caffeine
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 1, 2011
FDA Product Classification

INGREDIENTS (8)

BUTALBITALActive
Quantity: 50 mg in 1 1
Code: KHS0AZ4JVK
Classification: ACTIB
ASPIRINActive
Quantity: 325 mg in 1 1
Code: R16CO5Y76E
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CAFFEINEActive
Quantity: 40 mg in 1 1
Code: 3G6A5W338E
Classification: ACTIB
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
HYDROGENATED COTTONSEED OILInactive
Code: Z82Y2C65EA
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Butalbital, Aspirin and Caffeine - FDA Drug Approval Details